BIO 2014 Wednesday Round-Up: The Search For Innovation
This article was originally published in The Pink Sheet Daily
BIO was abuzz on day three of the conference with excitement over keynote speaker Hillary Clinton as her secret service presence was detected even in the early hours of the day. Meanwhile panelists continued to address the hot topics of collaboration, international growth and oncology.
You may also be interested in...
With $230 million from industry and NIH, the Accelerating Medicines Partnership will seek to hasten and improve the success rate for discovery of biomarkers and therapeutic pathways in Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus.
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.
The biotech is shifting gears after clinical hold on its lead drug was unlikely to be lifted, but the early-stage candidate that it's placing its hopes on is raising red flags for analysts and investors.